Screener
Insmed INSM EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Insmed’s reported figures.
The source filing: Insmed’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:59 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104506-26-000041
FAQ
- What is Insmed's EBITDA?
- Insmed (INSM) reported EBITDA of $3.71M in Q2 2026.
- How has Insmed's EBITDA changed year-over-year?
- Insmed's EBITDA increased by 101.2% year-over-year, from -$309.13M to $3.71M.
- What is the long-term trend for Insmed's EBITDA?
- Over 4 years (2021 to 2025), Insmed's EBITDA has grown at a 35.4% compound annual growth rate (CAGR), from -$365.99M to -$1.23B.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Insmed's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude